Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jul 20, 2009

The Leukemia & Lymphoma Society Taps Forma for Preclinical Activities

  • Forma Therapeutics agreed to help advance The Leukemia & Lymphoma Society (LLS) projects entering late preclinical development. The partnership will kick off with the selection of 10 small molecule candidates, discovered by LLS-funded academic researchers.

    Forma will use its computational solvent mapping technology for structure-based drug design. The company will also leverage its computer modeling, screening, and medicinal chemistry competence to optimize and prioritize molecules that LLS and its partners may take to the clinic.



Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »